Literature DB >> 32145792

Challenging the management of drug-resistant tuberculosis.

Hannah Yejin Kim1, Scott K Heysell2, Stella Mpagama3, Ben J Marais4, Jan-Willem Alffenaar5.   

Abstract

Entities:  

Year:  2020        PMID： 32145792     DOI： 10.1016/S0140-6736(20)30049-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment.

Authors:  Hannah Yejin Kim; Shashikant Srivastava; Hemanth Kumar Ak; Ben J Marais; Jan-Willem Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

2.  Levofloxacin pharmacokinetics in saliva as measured by a mobile microvolume UV spectrophotometer among people treated for rifampicin-resistant TB in Tanzania.

Authors:  Sagal Mohamed; Happiness C Mvungi; Margaretha Sariko; Prakruti Rao; Peter Mbelele; Erwin M Jongedijk; Claudia A J van Winkel; Daan J Touw; Suzanne Stroup; Jan-Willem C Alffenaar; Stellah Mpagama; Scott K Heysell
Journal:  J Antimicrob Chemother       Date:  2021-05-12       Impact factor: 5.790

Review 3.  Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs.

Authors:  Marieke G G Sturkenboom; Anne-Grete Märtson; Elin M Svensson; Derek J Sloan; Kelly E Dooley; Simone H J van den Elsen; Paolo Denti; Charles A Peloquin; Rob E Aarnoutse; Jan-Willem C Alffenaar
Journal:  Clin Pharmacokinet       Date:  2021-03-06       Impact factor: 6.447

4.  Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China.

Authors:  Xubin Zheng; Lina Davies Forsman; Ziwei Bao; Yan Xie; Zhu Ning; Thomas Schön; Judith Bruchfeld; Biao Xu; Jan-Willem Alffenaar; Yi Hu
Journal:  Eur Respir J       Date:  2022-03-24       Impact factor: 16.671

5.  Practices of therapeutic drug monitoring in tuberculosis: an international survey.

Authors:  Ioana Margineanu; Onno Akkerman; Dario Cattaneo; Delia Goletti; Deborah J E Marriott; Giovanni Battista Migliori; Fuad Mirzayev; Charles A Peloquin; Ymkje Stienstra; Jan-Willem Alffenaar
Journal:  Eur Respir J       Date:  2022-04-14       Impact factor: 33.795

6.  A mobile microvolume UV/visible light spectrophotometer for the measurement of levofloxacin in saliva.

Authors:  Jan-Willem C Alffenaar; Erwin M Jongedijk; Claudia A J van Winkel; Margaretha Sariko; Scott K Heysell; Stellah Mpagama; Daan J Touw
Journal:  J Antimicrob Chemother       Date:  2021-01-19       Impact factor: 5.790
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.